Interleukin 6 receptor blockers (IL-6RB) show promising results in reducing relapses in MOGAD compared to IVIG, despite limited studies. PMID:42440328, JAMA Neurol 2026, @JAMANeuro https://doi.org/10.1001/jamaneurol.2026.2220 #Medsky #Pharmsky #RNA #ASHG …
So far, Altmetric has seen
5 Bluesky posts from 5 Bluesky users, with an upper bound of 4,704 followers.
1,940 followers
118 followers
0 followers
2,634 followers
RP @themogproject.bsky.social: Promising news for the MOGAD community! A new international study found that IL-6 receptor blockers (primarily tocilizumab) were associated with lower relapse rates and a favorable safety profile in people living with MOG…